AGP Executive Report

Medicines & Justice: The Dutch Public Prosecution Service says it can link another three deaths to substances sold via Funcaps, bringing the total to 21, with two more deaths still under toxicology review. Public Health & Safety: Police continue investigating the mysterious Amsterdam “Lucky” case after a renewed push to identify the man, including possible links to Canada, following a 2023 collapse that left him with speech and language problems. LGBTQ+ Rights: Prime Minister Rob Jetten warns that acceptance of LGBTQ+ rights among Dutch youth is “under huge pressure,” pointing to political debate that could roll back trans healthcare. Climate & Health Risk: A new study warns Europe’s wildfire risk will worsen, with burned land potentially tripling by century’s end even under stronger climate action. MedTech Leadership (NL): Avania, based in Bilthoven, appoints Francis Duhay, MD, as Chief Medical Officer to expand therapeutic expertise for medical device and diagnostics trials. Food Safety & Hygiene: A European food-safety expert stresses that hygiene and training are “non-negotiable,” citing growing interest in Indian restaurant investment in the Netherlands. Research & Prenatal Care: A review discusses how genome-wide prenatal cfDNA screening adds interpretive complexity because much of the DNA comes from the placenta, not just the fetus.

Assisted Dying in France: France has officially legalised assisted dying, with the new “right to assisted dying” law coming into effect after constitutional approval and a final signing by President Macron. Healthcare Regulation & Media: The Dutch Healthcare Inspectorate has fined Dutch newspapers for “promoting” Ozempic, adding pressure on how weight-loss drugs are covered in the media. Medicines & Research: A blood pressure drug is reported to potentially slow a rare childhood brain disease, while researchers also report a breakthrough in neuromedicine by keeping human mini-brains alive for years. Dutch Health Workforce: New figures show the number of non-EU dentists in the Netherlands has doubled in five years, underlining ongoing staffing and access pressures. Public Health & Food Safety: Belgium’s salmonella outbreak linked to contaminated eggs has climbed to around 300 cases, while the UK faces scrutiny over fruit and veg supply risks tied to climate change. Dutch Elm Disease Watch: In Canada, Red Deer is monitoring Dutch elm disease after rising cases in Edmonton, reflecting how plant health threats can spread across regions.

Dentistry Workforce: About a quarter of dentists practicing in the Netherlands now trained abroad, with EU-external inflow rising sharply as domestic training capacity lags. Regulation & Media: Dutch health regulators fined media outlets for “promoting” weight-loss prescription drugs like Ozempic, saying coverage went beyond allowed diabetes-only messaging. Assisted Dying Watch: France has moved to a legal right to assisted dying for eligible patients, joining a small group of countries including Belgium and the Netherlands. MRI Safety: A Netherlands-linked expert warns that a previous MRI doesn’t guarantee safety for future scans, stressing strict checks for implant type—especially for intracranial aneurysm clips. Food & Health: A Belgium Salmonella outbreak linked to eggs has climbed to 300 cases, while separate reporting highlights how climate disruption threatens fruit and veg supply and healthy diets. Healthcare Access Context: A call is made for an independent commission to study high-performing healthcare systems, explicitly looking at models including the Netherlands.

Opioid Treatment Access: Connecticut has started using state-funded mobile methadone units, with the first wave now serving northeastern areas—aiming to remove the “drive” barrier that can end treatment for people with opioid use disorder. AI in Biotech: A new wave of “biofoundries” is letting AI run parts of the design-build-test-learn cycle, speeding up cancer-targeting drug discovery. Rare Disease Drug Deal: BioMarin will buy Alesta Therapeutics for $275m upfront (up to $215m more later) to expand experimental treatments for a rare bone-wasting disorder. Clinical Diagnostics Case: Dutch clinicians report a rare Cushing’s disease diagnosis where standard tests conflicted—hair cortisol finally clarified the picture. Public Health & Safety: The NVWA warns holidaymakers and logistics firms to watch for Japanese beetles after a dead insect was found from an Italy shipment. Health Policy/Regulation: Healthcare Inspectorate fines Dutch newspapers for promoting Ozempic. International Cooperation: The Netherlands and Ghana sign a pact to intensify the fight against illicit drugs and drug markets.

GLP-1 Scrutiny in Dutch Media: The Health and Youth Care Inspectorate fined several Dutch outlets for reporting on Ozempic, Wegovy and Mounjaro, arguing the coverage “promoted” the drugs—sparking accusations of censorship. Patient Safety & Informed Consent: An investigation by Trouw says female sterilization clips can migrate and cause pain, but warnings were missing from Dutch distributor Entercare’s translated patient information. Premature Birth Mental Health: A Dutch nationwide study finds severe post-traumatic stress symptoms in 33% of mothers and 17% of fathers after very premature birth, urging mental healthcare to become routine in maternity care. Medicines Access Debate: ABN Amro argues the Dutch government should spend more on innovative medicines, warning strict reimbursement rules delay access and contribute to shortages. Climate & Health Risk: Coverage highlights how repeated European heatwaves are becoming a public health emergency, with some scientists debating solar geoengineering as a potential (and risky) intervention. Public Health Policy: The EU is revising tobacco rules to curb digital marketing and novel nicotine products as smoking and youth use remain a concern.

Rare disease breakthrough (Netherlands): Amsterdam UMC researchers report in The Lancet Neurology that guanabenz, an existing blood pressure drug, can slow progression of vanishing white matter, a rare fatal childhood brain disorder—fewer children became wheelchair-dependent and none died during the study period versus 5 in an international comparison group. Public health alert (Netherlands): RIVM confirms the Netherlands’ first locally acquired West Nile virus infection in a human blood donor since 2020; mild symptoms were reported, and Utrecht is designated a risk area with blood donations screened. Care access debate (Ireland, EU context): Irish politicians urge Biogen to consider a compassionate access programme for Friedreich’s ataxia after reimbursement was rejected due to cost and uncertainty around clinical efficacy. Science integrity (Netherlands-linked): The BMJ retracts a Netherlands-linked paper on COVID vaccines and excess deaths, citing misleading discussion and insufficient description of limitations; one author has resigned. Health tech market (Netherlands industry): A new report projects strong growth for surgical imaging through 2030, naming Philips among key players.

Public Health Alert: The Netherlands has reported its first West Nile virus infection since 2020, according to RIVM. The person had mild symptoms and had not recently travelled, suggesting local transmission via mosquitoes. Medical Research: Amsterdam UMC researchers report that an existing blood pressure drug, guanabenz, may slow progression of vanishing white matter, a rare and often fatal childhood brain disease, in a Lancet Neurology study. Immunology Update: Belgian-Dutch biotech argenx says efgartigimod met the primary goal in a Phase 3 trial for autoimmune myositis, with significant improvement in disease activity at 52 weeks versus placebo. Healthcare Access & Costs: A survey of Dutch AOW recipients finds 69% are postponing larger or nonessential purchases due to rising living costs, with energy, groceries and even health-related expenses squeezing budgets. Policy & Care: The Jetten Cabinet begins talks with opposition parties ahead of the September 15 budget deadline, with healthcare deductible increases among the sticking points.

Rare Childhood Brain Disease: Amsterdam UMC-led research in The Lancet Neurology suggests the existing blood pressure drug guanabenz may slow vanishing white matter progression in children, with fewer wheelchair dependencies and no deaths in the treated group. Heart Failure Treatment: UMCG cardiologists report low-dose digoxin could reduce hospitalisations and death risk in heart failure, potentially adding an affordable option to standard care. Public Health & Research Integrity: The British Medical Journal retracted a 2024 paper on COVID-era excess deaths, citing problematic discussion around causes; an internal probe found no misconduct. Drug Policy Cooperation: Ghana and the Netherlands signed a Letter of Intent to tackle illicit drugs and dismantle criminal networks behind drug markets. Emergency Care Innovation: A Dutch student team unveiled “Stella Juva,” described as the world’s first solar-powered ambulance, designed to deliver care in off-grid areas. Wildfire Health Risks: Belgium’s High Fens wildfire prompted evacuations and EU support, with smoke posing health hazards for nearby communities. Travel & Care Access: A report highlights that travel medical insurance is typically required for Schengen trips and should cover the full stay.

Opioid treatment access: Connecticut’s first state-funded mobile methadone vans are expanding care for people with opioid use disorder, cutting the daily travel and “dosing window” barriers that can derail recovery. Diabetes & diet drinks: A Dutch cohort study from Amsterdam UMC suggests that switching to non-sugar-sweetened fizzy drinks may not protect against type 2 diabetes—and could raise risk, especially for younger adults and people of non-Dutch origin. Rare childhood brain disease: Amsterdam UMC researchers report that an existing blood pressure medication (guanabenz) may slow progression of vanishing white matter in children, with fewer wheelchair dependencies and no deaths in the treated group during follow-up. Alzheimer’s genetics: New findings show APOE and a broader polygenic Alzheimer risk score can shift age at onset in people with an extra APP gene copy (including APP duplication and Down syndrome). Healthcare quality in the Dutch Caribbean: Medical Institute San Nicolas (ImSan) in Aruba received JCI Gold Seal of Approval after international reaccreditation, highlighting patient safety and continuous quality improvement. Public health & environment: Record Dutch heat is linked to broader European heatwave impacts, while scientists warn that “zero-sugar” swaps may not deliver the diabetes protection people expect.

Rare disease drug repurposing (Netherlands): Amsterdam UMC reports that the existing blood pressure medicine guanabenz may slow progression of vanishing white matter, a fatal childhood brain disorder, with fewer deaths and slower wheelchair dependence in a 3-year follow-up. Hospital quality (Dutch Caribbean): The Medical Institute San Nicolas (ImSan) in Aruba received JCI’s Gold Seal of Approval after international reaccreditation, highlighting patient safety and continuous quality improvement. Alzheimer genetics (international, Netherlands-linked research): A study in Alzheimer’s & Dementia finds APOE variants and a broader polygenic risk score can shift Alzheimer onset timing in people with an extra APP gene copy (including APPdup and Down syndrome). PED use survey (Netherlands): A Netherlands-based study suggests performance-enhancing drug use in gyms is far higher than standard questionnaires show, with comfort-focused questioning producing much larger estimates. Cybersecurity (Philips, Shell): Clop ransomware claims breaches tied to a PTC Windchill flaw, naming Philips and Shell among 43 targets—urging organizations to patch and check systems. Mental health access (Netherlands context): A report says around 62,500 people in the Netherlands are not in treatment for serious mental health problems. Public health & safety (Netherlands): Netherlands hit record heat levels, raising concerns for health impacts during extreme temperatures.

Heat & health: The Netherlands just logged its hottest Aug. 13 ever, with De Bilt hitting 32.2°C and the country breaking its record for days above 30°C, while the national heat plan and Code Yellow alerts were activated to protect older adults and people with chronic conditions. Diabetes & drinks: An Amsterdam-based study links higher intake of non-sugar-sweetened beverages to a higher risk of type 2 diabetes, with substitution from sugary drinks to “diet” options also raising risk in younger adults and non-Dutch groups. Animal health & farming costs: Bluetongue virus serotype 3 has reached Scotland, triggering movement controls and raising fears of direct losses (fertility, milk, growth) plus extra vet and vaccination costs. Public safety: A firefighter died and three people were seriously injured in gas explosions near Brussels Central Station after a construction accident damaged a gas pipe. Care policy in Europe: France’s constitutional authority approved assisted dying for some adults with incurable conditions, while striking down a children’s social media ban.

Heat & Health: The Netherlands logged its hottest Aug. 13 ever and set a new record for days above 30°C, with the national heat plan activated and extra focus on older adults and people with chronic conditions. Diabetes Nutrition: An Amsterdam-based multiethnic study found higher intake of non-sugar-sweetened beverages was linked to higher type 2 diabetes risk, and swapping sugar drinks for non-sugar options didn’t reduce risk for some groups. Wearables & Safety: Google’s Pixel Watch 5 adds breathing emergency detection that can call emergency services if oxygen drops and the wearer doesn’t respond. Food & Public Health: Lidl is testing Paw Patrol stickers on healthy foods in the Netherlands, aiming to steer kids toward fruit and vegetables that meet the Schijf van Vijf criteria. Workplace Health: A gas explosion near Brussels Central Station killed a firefighter and seriously injured three others, underscoring risks during construction and utility work. Research Tools: MIT researchers demonstrated a fast microscope approach to track electrical activity across the brain in milliseconds using zebrafish. Care Access Tech: AS Watson’s Kruidvat in the Netherlands is set to roll out NCR Voyix retail tech to expand offline-plus-online shopping services.

Heat Health Alert: The KNMI and RIVM have issued a code yellow as the Netherlands faces its fifth heatwave of the year, with temperatures up to 37°C on Friday and care homes and health services on alert. Kidney Care Research: A randomized trial in JAMA reports that patients given dapagliflozin before elective cardiac surgery had a lower risk of postoperative acute kidney injury (AKI), with low rates of euglycemic diabetic ketoacidosis. Public Health & Climate Risk: Western Europe’s record heat is driving wildfires and major economic losses, with AFP estimating 150 million people in Europe will see 35°C+ today. Local Health & Safety: A Rotterdam port explosion has killed at least one person and injured several others, underlining ongoing risks around industrial sites. Health Tech & Diagnostics: A Bengaluru startup pairs trained sniffer dogs with AI to flag early signs of cancer from breath samples, positioning it as prescreening rather than a proven diagnosis. Animal Health & Consumer Protection: An Amsterdam court convicted a man for defrauding 14 buyers with sickly, unvaccinated Pomeranian puppies sold via Marktplaats, including forged animal passports.

Diabetes & Medication Safety (Netherlands): A Dutch study in JAMA Network Open finds that starting antipsychotics in people aged 19 and under is linked to a rapid, sustained rise in pharmacologically treated type 2 diabetes risk over the next five years, with the biggest jump in the first year. Rare Childhood Brain Disease (Amsterdam): Amsterdam UMC researchers report that the blood pressure drug guanabenz may slow progression of vanishing white matter, a rare hereditary condition in young children, though it does not cure it. Workplace Health & Safety (Rotterdam): A blast at Gunvor Energy’s Europoort facility in the Port of Rotterdam killed one person and sent several others to hospital; investigators and the Dutch labour inspectorate are still looking at possible causes, with earlier port power issues reported as unrelated. Public Health Research (Cross-species neuroscience): Scientists have built a new cross-species brain map linking mouse and marmoset regions, aiming to make animal-to-human research comparisons more reliable. Healthcare Innovation (Pharma/Patents): Novartis won a UK High Court bid to invalidate its Entresto patent, a boost as the company faces multiple upcoming patent expiries. Animal Welfare (Dutch model abroad): Johor (Malaysia) plans to adopt the Netherlands’ approach to stray animals—sterilisation, shelter care, and adoption—working with NGOs.

Heat & Public Health: The Netherlands has hit a new record for tropical days, with 31 days of 30°C+ already logged (beating 1947’s 30). KNMI links the surge to climate change, and RIVM has reactivated its national heat plan, urging extra checks on elderly people and young children as temperatures could reach 33–37°C. Alcohol Guidance Watch: Nearly half of Dutch people still think a daily drink is fine despite new Health Council advice that even one glass a day is harmful; younger adults are cutting back more, and alcohol-free beer sales are rising. Rare Disease Access: Pharming launched Joenja (leniolisib) in Japan for APDS patients aged 4+ after it was added to the national reimbursement list—an early sign of expanding treatment options for rare immune disorders. Wearable Safety Tech: Google says its “Breathing Emergency Detection” feature is now available on both Pixel Watch 4 and 5 in multiple European countries, using AI to detect potential breathing emergencies and call emergency services. Mental Health Need: A report says around 62,500 people in the Netherlands are not in treatment despite serious mental health problems.

Patient Monitoring Push: Philips (Amsterdam) added six tech partners—Blue Spark, Caretaker Medical, Cuviva, LifeSignals, Respiree and smartQare—to expand remote and hospital-at-home monitoring, with data from vitals like blood pressure, ECG, oxygen saturation, respiratory rate, temperature and activity feeding into its PIC iX system. Mental Health Access in NL: A report flags that around 62,500 people in the Netherlands are not in treatment for serious mental health problems, highlighting ongoing gaps in care pathways. Research & Trials in Europe: EMA-related events in Amsterdam point to continued momentum on clinical trials infrastructure and patient/consumer and healthcare-professional working parties meeting in October 2026. Health Tech Watch: Google is testing AMIE for clinical video consultations, while privacy concerns keep growing around camera-equipped wearables in healthcare settings. Care Workforce & Safety: Dutch health services say day care heat protocols fall short in protecting children, adding pressure on summer safety standards.